Sign in to edit your profile (add interests, mentoring, photo, etc.)

    Erin Reid

    TitleClinical Professor
    SchoolUniversity of California, San Diego
    Address9500 Gilman Drive #0987
    CA La Jolla 92093

      Research Interests
      Dr. Reid’s broad research interests are to develop and conduct clinical trials for hematologic malignancies. She has made significant progress in the developing a concentration on AIDS-related lymphoma and Kaposi’s sarcoma.

      Education and Training
      BS - Biology, Stanford University - 1994
      MD - University of California, San Francisco - 1999
      Resident - Stanford University - 1999-2001
      Fellow - Hematology-Oncology, Stanford University - 2001-2003
      Fellow - Hematology-Oncology, University of California, San Diego - 2004
      MS - Epidemiology, Stanford University - 2006

       ORNG Applications 

      Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
      List All   |   Timeline
      1. Mirheydar HS, Banapour P, Massoudi R, Palazzi KL, Jabaji R, Reid EG, Millard FE, Kane CJ, Sur RL. What is the Incidence of Kidney Stones after Chemotherapy in Patients with Lymphoproliferative or Myeloproliferative Disorders? Int Braz J Urol. 2014 Nov-Dec; 40(6):772-80.
        View in: PubMed
      2. Koon HB, Krown SE, Lee JY, Honda K, Rapisuwon S, Wang Z, Aboulafia D, Reid EG, Rudek MA, Dezube BJ, Noy A. Phase II Trial of Imatinib in AIDS-Associated Kaposi's Sarcoma: AIDS Malignancy Consortium Protocol 042. J Clin Oncol. 2014 Feb 10; 32(5):402-8.
        View in: PubMed
      3. Gopal S, Patel MR, Yanik EL, Cole SR, Achenbach CJ, Napravnik S, Burkholder GA, Reid EG, Rodriguez B, Deeks SG, Mayer KH, Moore RD, Kitahata MM, Richards KL, Eron JJ. Association of early HIV viremia with mortality after HIV-associated lymphoma. AIDS. 2013 Sep 24; 27(15):2365-73.
        View in: PubMed
      4. DeBoever C, Reid EG, Smith EN, Wang X, Dumaop W, Harismendy O, Carson D, Richman D, Masliah E, Frazer KA. Whole transcriptome sequencing enables discovery and analysis of viruses in archived primary central nervous system lymphomas. PLoS One. 2013; 8(9):e73956.
        View in: PubMed
      5. Kozak I, Reid EG. Retinal vein occlusion during flare of multicentric Castleman's disease. Clin Ophthalmol. 2013; 7:1647-9.
        View in: PubMed
      6. Gopal S, Patel MR, Yanik EL, Cole SR, Achenbach CJ, Napravnik S, Burkholder GA, Reid EG, Rodriguez B, Deeks SG, Mayer KH, Moore RD, Kitahata MM, Eron JJ, Richards KL. Temporal trends in presentation and survival for HIV-associated lymphoma in the antiretroviral therapy era. J Natl Cancer Inst. 2013 Aug 21; 105(16):1221-9.
        View in: PubMed
      7. Levine AM, Noy A, Lee JY, Tam W, Ramos JC, Henry DH, Parekh S, Reid EG, Mitsuyasu R, Cooley T, Dezube BJ, Ratner L, Cesarman E, Tulpule A. Pegylated liposomal doxorubicin, rituximab, cyclophosphamide, vincristine, and prednisone in AIDS-related lymphoma: AIDS Malignancy Consortium Study 047. J Clin Oncol. 2013 Jan 1; 31(1):58-64.
        View in: PubMed
      8. Bayraktar UD, Ramos JC, Petrich A, Gupta N, Lensing S, Moore PC, Reid EG, Aboulafia DM, Ratner L, Mitsuyasu R, Cooley T, Henry DH, Barr P, Noy A. Outcome of patients with relapsed/refractory acquired immune deficiency syndrome-related lymphoma diagnosed 1999-2008 and treated with curative intent in the AIDS Malignancy Consortium. Leuk Lymphoma. 2012 Dec; 53(12):2383-9.
        View in: PubMed
      9. Krown SE, Roy D, Lee JY, Dezube BJ, Reid EG, Venkataramanan R, Han K, Cesarman E, Dittmer DP. Rapamycin with antiretroviral therapy in AIDS-associated Kaposi sarcoma: an AIDS Malignancy Consortium study. J Acquir Immune Defic Syndr. 2012 Apr 15; 59(5):447-54.
        View in: PubMed
      10. Reid E, Morris SR. HIV Co-receptor usage in HIV-related non-hodgkin's lymphoma. Infect Agent Cancer. 2012; 7(1):6.
        View in: PubMed
      11. Reid E, Nooka A, Blackmon J, Lechowicz MJ. Clinical use of rituximab in patients with HIV related lymphoma and Multicentric Castleman's disease. Curr Drug Deliv. 2012 Jan; 9(1):41-51.
        View in: PubMed
      12. Reid EG. Bortezomib-induced Epstein-Barr virus and Kaposi sarcoma herpesvirus lytic gene expression: oncolytic strategies. Curr Opin Oncol. 2011 Sep; 23(5):482-7.
        View in: PubMed
      Back to TOP